News
ENOV
21.08
-2.36%
-0.51
Weekly Report: what happened at ENOV last week (1012-1016)?
Weekly Report · 4d ago
2 Stocks Under $50 Worth Your Attention and 1 We Turn Down
Barchart · 10/15 03:48
3 Healthcare Stocks We Find Risky
Barchart · 10/13 02:44
Enovis Price Target Cut to $34.00/Share From $52.00 by Needham
Dow Jones · 10/12 10:22
Weekly Report: what happened at ENOV last week (1005-1009)?
Weekly Report · 10/12 10:19
Enovis (ENOV) Stock Looks Undervalued Based On Future Cash Flow
Simply Wall St · 10/11 02:32
Enovis (ENOV) Reaffirms Guidance On Strong Q2 Sales So Is The Selloff A Bargain
Simply Wall St · 10/08 18:27
Analysts Offer Insights on Healthcare Companies: Trulieve Cannabis (TRLV) and Enovis (ENOV)
TipRanks · 10/05 13:30
Weekly Report: what happened at ENOV last week (0928-1002)?
Weekly Report · 10/05 10:18
Weekly Report: what happened at ENOV last week (0921-0925)?
Weekly Report · 09/28 10:14
1 Oversold Stock Ready to Bounce Back and 2 That Underwhelm
Barchart · 09/28 04:20
Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
PR Newswire · 09/22 16:02
Weekly Report: what happened at ENOV last week (0914-0918)?
Weekly Report · 09/21 10:14
Enovis management to meet virtually with Freedom Capital
TipRanks · 09/17 19:50
Insider at Medical Device Maker Buys More Than 7,500 Shares
The Motley Fool · 09/14 14:15
Weekly Report: what happened at ENOV last week (0907-0911)?
Weekly Report · 09/14 10:19
Wells Fargo Remains a Buy on Enovis (ENOV)
TipRanks · 09/09 10:26
Tuesday 9/8 Insider Buying Report: ENOV, OBIO
NASDAQ · 09/08 17:51
CEO & Director of Enovis Picks Up 50% More Stock
Simply Wall St · 09/07 10:18
Weekly Report: what happened at ENOV last week (0831-0904)?
Weekly Report · 09/07 10:13
More
Webull provides a variety of real-time ENOV stock news. You can receive the latest news about Enovis Corp through multiple platforms. This information may help you make smarter investment decisions.
About ENOV
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).